124 related articles for article (PubMed ID: 34733084)
1. Assessment of a Medication Deprescribing Tool on Polypharmacy and Cost Avoidance.
Constantino-Corpuz JK; Alonso MTD
Fed Pract; 2021 Jul; 38(7):332-336. PubMed ID: 34733084
[TBL] [Abstract][Full Text] [Related]
2. Use of a Deprescribing Tool in an Interdisciplinary Primary-Care Patient-Aligned Care Team.
Nelson MW; Downs TN; Puglisi GM; Simpkins BA; Collier AS
Sr Care Pharm; 2022 Jan; 37(1):34-43. PubMed ID: 34953511
[No Abstract] [Full Text] [Related]
3. Pharmacist-driven deprescribing initiative in primary care.
Rea E; Portman D; Ioannou K; Lumley B
J Am Pharm Assoc (2003); 2024; 64(1):139-145. PubMed ID: 37722503
[TBL] [Abstract][Full Text] [Related]
4. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
5. Understanding Principles of High Reliability Organizations Through the Eyes of VIONE: A Clinical Program to Improve Patient Safety by Deprescribing Potentially Inappropriate Medications and Reducing Polypharmacy.
Battar S; Watson Dickerson KR; Sedgwick C; Cmelik T
Fed Pract; 2019 Dec; 36(12):564-568. PubMed ID: 31892781
[TBL] [Abstract][Full Text] [Related]
6. Informatics Tools in Deprescribing and Medication Optimization in Older Adults: Development and Dissemination of VIONE Methodology in a High Reliability Organization.
Winter SG; Sedgwick C; Wallace-Lacey A; Dickerson K; Battar S; Hung W
Clin Ther; 2023 Oct; 45(10):928-934. PubMed ID: 37690914
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy, Medication Possession, and Deprescribing of Potentially Non-Beneficial Drugs in Hospice Patients.
Duncan I; Maxwell TL; Huynh N; Todd M
Am J Hosp Palliat Care; 2020 Dec; 37(12):1076-1085. PubMed ID: 32662276
[TBL] [Abstract][Full Text] [Related]
8. A virtual breakthrough series collaborative to support deprescribing interventions across Veterans Affairs healthcare settings.
Phillips KK; Mecca MC; Baim-Lance AM; Schiller GS; Pruskowski JA; Ellis EC; Aponte-Rosario DS; Federovich-Hogan AL; Kossifologos AC; Martinez ED; Boockvar KS
J Am Geriatr Soc; 2023 Sep; 71(9):2935-2945. PubMed ID: 37337658
[TBL] [Abstract][Full Text] [Related]
9. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
[TBL] [Abstract][Full Text] [Related]
10. Deprescribing as a Clinical Improvement Focus.
Dharmarajan TS; Choi H; Hossain N; Munasinghe U; Lakhi F; Lourdusamy D; Onuoha S; Murakonda P; Skokowska-Lebelt A; Kanagala M; Russell RO
J Am Med Dir Assoc; 2020 Mar; 21(3):355-360. PubMed ID: 31672564
[TBL] [Abstract][Full Text] [Related]
11. Implementation of a Pilot PharmD Medication Optimization Telehealth Clinic Within a Veterans Affairs System.
Faulkner W; DiScala SL; Quellhorst JA; Dakroub B
Sr Care Pharm; 2024 May; 39(5):193-201. PubMed ID: 38685620
[No Abstract] [Full Text] [Related]
12. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
[TBL] [Abstract][Full Text] [Related]
13. The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care.
McDonald EG; Wu PE; Rashidi B; Forster AJ; Huang A; Pilote L; Papillon-Ferland L; Bonnici A; Tamblyn R; Whitty R; Porter S; Battu K; Downar J; Lee TC
J Am Geriatr Soc; 2019 Sep; 67(9):1843-1850. PubMed ID: 31250427
[TBL] [Abstract][Full Text] [Related]
14. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
[TBL] [Abstract][Full Text] [Related]
15. Deprescribing opportunities for elderly inpatients in an academic, safety-net health system.
Bredhold BE; Deodhar KS; Davis CM; DiRenzo BM; Isaacs AN; Campbell NL
Res Social Adm Pharm; 2021 Mar; 17(3):541-544. PubMed ID: 32402730
[TBL] [Abstract][Full Text] [Related]
16. Physicians' perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study.
Tangiisuran B; Rajendran V; Sha'aban A; Daud NAA; Nawi SNM
Int J Clin Pharm; 2022 Feb; 44(1):201-213. PubMed ID: 34642869
[TBL] [Abstract][Full Text] [Related]
17. Polypharmacy: Evaluating Risks and Deprescribing.
Halli-Tierney AD; Scarbrough C; Carroll D
Am Fam Physician; 2019 Jul; 100(1):32-38. PubMed ID: 31259501
[TBL] [Abstract][Full Text] [Related]
18. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
[TBL] [Abstract][Full Text] [Related]
19. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.
Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D
Int J Clin Pharm; 2015 Oct; 37(5):949-57. PubMed ID: 26047944
[TBL] [Abstract][Full Text] [Related]
20. Deprescribing to Reduce Medication Use: Will This Help Your Patient?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2016 Nov; 54(11):21-24. PubMed ID: 27805712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
